中文 English
Home
Patient Center
Clinical Trial
About Us
Chairman’s Message Our Company Leadership
Research&Development
Areas of Focus Pipeline
Newsroom
Company News Guidelines&Recomandations Publications
Contact Us
Contacts
Learn More
Gensciences receives FDA Orphan Drug Designation for FRSW117, once-a-week ultra-long-acting recombinant coagulation FVIII Drugs
2024-09-26
Learn More
Gensciences will Expose Its Data at ISTH 2024
2024-06-17
Learn More
Gensciences Inc. Initiated Phase III Clinical Trial for Its Ultra-Long-Acting Recombinant Coagulation Factor VIII with Once-Weekly Dosing Regimen!
2023-12-25
Learn More
More News
Research&Development
Learn More
Areas of Focus
Pipeline
Address
Jiangsu Gensciences：South of Xinxing Road, West of Guangxian Road, Nantong Economic Technolog Development Zone, Jiangsu
Beijing Gensciences：Building 18, Area B, BUT Software Park, 1 Disheng North Street, Daxing District, Beijing
Zhengzhou Gensciences：Building 20, Zhengzhou Linkong Biomedical Park, Zhengzhou Airport Economy District, Henan
Shanghai Gensciences：Building 5, Lane 111, Liangyao Road, Xinchang Township, Pudong New Area, Shanghai
Links
Home
Patient Center
About Us
Research&Development
Newsroom
Contact Us
WeChat Public Account

Scan to Add

Copyright: Jiangsu Gensciences Inc.     苏ICP备2022048559号-2    ghs苏公网安备32060002000102号